CN Patent

CN113966224A — 采用补体抑制剂的炎性疾病治疗

Assigned to UCB Inc · Expires 2022-01-21 · 4y expired

What this patent protects

本公开提供了用补体抑制剂化合物和组合物治疗炎性适应症的方法。包括治疗神经肌肉炎性适应症例如免疫介导的坏死性肌病的化合物和方法。

USPTO Abstract

本公开提供了用补体抑制剂化合物和组合物治疗炎性适应症的方法。包括治疗神经肌肉炎性适应症例如免疫介导的坏死性肌病的化合物和方法。

Drugs covered by this patent

zilucoplan-sodium (ZILUCOPLAN SODIUM)

Patent Metadata

Patent number: CN113966224A
Jurisdiction: CN
Classification: —
Expires: 2022-01-21
Drug substance claim: No
Drug product claim: No
Assignee: UCB Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.